Oncotarget
The cover for issue 39 of Oncotarget features Figure 4, "Apoptosis assay of NRXN1-targeted ADC at IC50 dose calculated by growth inhibition curves," by Yotsumoto, et al.
Minority MOMP: a toxic, slow demise |
https://doi.org/10.18632/oncotarget.27753 Yuan Xu, Deborah R. Surman, and R. Taylor Ripley |
3559-3561 |
PDF | How to cite | Order a Reprint |
Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential |
https://doi.org/10.18632/oncotarget.27749 Chao-Chieh Lin, and Jen-Tsan Chi |
3562-3570 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy |
https://doi.org/10.18632/oncotarget.27731 Wojciech Dawicki, Kevin J.H. Allen, Ravendra Garg, Eileen M. Geoghegan, Mark S. Berger, Dale L. Ludwig, and Ekaterina Dadachova |
3571-3581 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
PD-1/PD-L1 expression in anal squamous intraepithelial lesions |
https://doi.org/10.18632/oncotarget.27756 Margot Bucau, Nathalie Gault, Nanthara Sritharan, Emy Valette, Charlotte Charpentier, Francine Walker, Anne Couvelard, and Laurent Abramowitz |
3582-3589 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer |
https://doi.org/10.18632/oncotarget.27718 Takuma Yotsumoto, Keita Maemura, Kousuke Watanabe, Yosuke Amano, Yoko Matsumoto, Koichi Zokumasu, Takahiro Ando, Masanori Kawakami, Hidenori Kage, Jun Nakajima, Yutaka Yatomi, Takahide Nagase, and Daiya Takai |
3590-3600 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
Meta-analysis of gene expression profiling reveals novel basal gene signatures in MCF-10A cells transformed with cadmium |
https://doi.org/10.18632/oncotarget.27734 Katrina Blommel, Carley S. Knudsen, Kyle Wegner, Swojani Shrestha, Sandeep K. Singhal, Aaron A. Mehus, Scott H. Garrett, Sonalika Singhal, Xudong Zhou, Brent Voels, Donald A. Sens, and Seema Somji |
3601-3617 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity |
https://doi.org/10.18632/oncotarget.27349 Adrienne L. Watson, Bryant J. Keller, Kyle A. Williams, Namrata N. Damle, Samuel J. Finnerty, Leah K. Anderson, Andrew D. Greeley, Vincent W. Keng, Eric P. Rahrmann, Amanda L. Halfond, Natasha M. Powell, Margaret H. Collins, Tilat Rizvi, Christopher L. Moertel, Nancy Ratner, and David A. Largaespada |
3618-3620 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC